Combined Oral Contraceptive Pill and Resistance Starch

计划入组 100 人 · 首次发布于 2025 年 2 月 28 日

Screening of Multidrug Resistant Bacteria, and the Clinical Implication for the Patient

计划入组 10,000 人 · 首次发布于 2024 年 4 月 17 日

Use of New Antibiotics in Sweden

计划入组 41 人 · 首次发布于 2021 年 9 月 17 日

Shujinjianyao Pill

Huangshixiangsheng Pill

FTZnongsuo Pill

Ensysce Biosciences

United States

UNION MULTI CULTURES GUADELOUPEENNE

Guadeloupe

HCG MULTI SPECIALTY HOSPITAL

India

Ensysce Biosciences Secures Patent for Novel Methadone-Based Opioid Use Disorder Treatment

Ensysce Biosciences Enrolls First Patient in Pivotal Phase 3 Trial for Abuse-Resistant Opioid PF614

Ensysce Biosciences Secures Supply and Partnership to Advance Abuse-Resistant Pain Relief